|
USP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.476200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.699780E-02 |
| Normal-vs-Stage2 |
5.482400E-01 |
| Normal-vs-Stage3 |
4.738000E-01 |
| Normal-vs-Stage4 |
2.851700E-02 |
| Stage1-vs-Stage2 |
1.913720E-02 |
| Stage1-vs-Stage3 |
1.335370E-01 |
| Stage1-vs-Stage4 |
6.550400E-01 |
| Stage2-vs-Stage3 |
2.443800E-01 |
| Stage2-vs-Stage4 |
2.893600E-02 |
| Stage3-vs-Stage4 |
1.304820E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.158000E-02 |
| Normal-vs-AfricanAmerican |
2.323800E-01 |
| Normal-vs-Asian |
3.875900E-02 |
| Caucasian-vs-AfricanAmerican |
8.692600E-01 |
| Caucasian-vs-Asian |
6.122600E-01 |
| AfricanAmerican-vs-Asian |
6.026800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.131800E-02 |
| Normal-vs-Female |
1.279800E-01 |
| Male-vs-Female |
1.950360E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.676100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.737390E-01 |
| Normal-vs-Age(61-80Yrs) |
8.417800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.449000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.084020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.848310E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.632800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.873800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.323200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.220000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.530000E-01 |
| Classical-VS-Follicular |
5.26640000053646E-07 |
| Classical-VS-Other |
7.363000E-01 |
| Classical-VS-Normal |
7.786100E-04 |
| Tall-VS-Follicular |
1.224190E-02 |
| Tall-VS-Other |
7.909600E-01 |
| Tall-VS-Normal |
2.607200E-01 |
| Follicular-VS-Other |
1.857040E-01 |
| Follicular-VS-Normal |
7.324400E-02 |
| Other-VS-Normal |
3.369200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.512200E-01 |
| Normal-vs-N1 |
1.708360E-01 |
| N0-vs-N1 |
2.238600E-01 |
|
|
